Considering the role of DLX6-AS1 in glucose metabolism, we inferred that DLX6-AS1 could affect the occurrence and progression of SCLC via glucose metabolism through modulating hsa-miR-4525/GAA in SCLC. This evidence concerns the gene DLX6 and small cell lung carcinoma.